Alex Gasner
Executive Vice President @ Roivant Sciences
New York, United States
Alex Gasner is a seed investor at Roivant Sciences in New York focused on Health Care and Risk Management. Alex Gasner is the Executive Vice President at Roivant Sciences.He attended Princeton University.
- Total investments:
- 2
- Last investment:
- Lead investor:
- 50%
Last updated:
For AI agents: llms.txt
Industries Alex Gasner invests in
Stages Alex Gasner invests in
Countries Alex Gasner invests in
Investment Focus
Industry
- Health Care 1 (50%)
- Risk Management 1 (50%)
- Data Visualization 1 (50%)
- Artificial Intelligence 1 (50%)
Stage
- Seed 1 (50%)
- Series A 1 (50%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Lokavant
|
Lokavant is an IT firm that offers real-time visualizations, risk alerts, artificial intelligence, and human insight services. | $21M / Series A / Dec 07, 2022 | |
Zest Health
|
Zest Dermatology is a value-based virtual clinic specializing in high-quality, cost-effective care for patients with eczema and psoriasis. As a subsidiary of Roivant, Zest partners with health plans, employers, pharmacy consultants, and brokers to optimize dermatology care while reducing specialty drug costs. Recognized by the V1C Coalition for itscommitment to evidence-based care, Zest participates in initiatives like the National Psoriasis Foundation's CP3 study to improve patient outcomes. By aligning with leading dermatologists and leveraging data-driven care models, Zest delivers innovative solutions for chronic skin conditions at scale. | $13M / Seed |
Co-Investors
About Roivant Sciences
Roivant Sciences is a biopharmaceutical company focused on completing the development of promising late-stage drug candidates.Roivant’s mission is to reduce the time and cost of developing new medicines for patients and to share those savings with the healthcare system. Roivant does this by building Vants - nimble, entrepreneurial biotech andhealthcare technology companies with a unique approach to sourcing talent, aligning incentives, and deploying the technology. In addition to its biopharmaceutical subsidiaries, Roivant also builds technology-focused Vants focused on improving the process of developing and commercializing medicines.
Roivant Sciences Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Alex Gasner
Executive Vice President
|
|||
Frank Torti
Vant Chair
|
|||
Matthew Gline
Chief Executive Officer
|
|||
Mayukh Sukhatme
Chief Investment Officer & President
|
|||
Benjamin Zimmer
President, Roivant Health
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Alex Gasner invest in?
Alex Gasner invests primarily in Health Care, Risk Management and Data Visualization startups, most often at Seed and Series A stage. Most of the 2 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Alex Gasner last invest?
The most recent investment recorded for Alex Gasner closed in Dec 2022. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
